MedPath

Abbott Biologicals B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.

Phase 3
Completed
Conditions
Influenza
Interventions
Biological: Trivalent influenza subunit vaccine Influvac
First Posted Date
2008-04-24
Last Posted Date
2008-08-13
Lead Sponsor
Solvay Biologicals
Target Recruit Count
120
Registration Number
NCT00665509
Locations
🇩🇪

Site 2, Hamburg, Germany

🇧🇪

Site 1, Tessenderlo, Belgium

© Copyright 2025. All Rights Reserved by MedPath